Incretin ‐based glucose‐lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio‐vascular outcome trials
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Michael A. Nauck, Juris J. Meier, Wolfgang E. Schmidt Tags: LETTER TO THE EDITOR Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Incretin Therapy | Obesity | Pancreas | Pancreatic Cancer | Pancreatitis